Glaucoma: Medical Treatments

Department of Health and Social Care written question – answered on 8th October 2019.

Alert me about debates like this

Photo of Jim Shannon Jim Shannon Shadow DUP Spokesperson (Human Rights), Shadow DUP Spokesperson (Health)

To ask the Secretary of State for Health and Social Care, whether he plans to make the biodegradable implant that replaces eye drops for glaucoma available on the NHS.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

Decisions about treatment should always be based on patients’ clinical needs. Clinical commissioning groups (CCGs) are required to commission healthcare services that meet the needs of their local population. To achieve this, they must assess local need, determining priorities and strategies, and commission services on behalf of their local population; overseeing those contracts to ensure high-quality care is provided.

National Health Service commissioners are legally required to fund treatments recommended in National Institute for Health and Care Excellence technology appraisal and highly specialised technologies guidance.

The future routine availability of any new or novel treatments would be subject to large scale clinical trials demonstrating the safety and efficacy of the treatment approach and subsequent assessments of its cost effectiveness for routine use.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.